CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
CD40 is essential in enabling antigen-presenting cells to process and present antigen effectively to T cells. We demonstrate here that when antibody against CD40 is used to treat mice with syngeneic lymphoma, a rapid cytotoxic T-cell response independent of T-helper cells occurs, with tenfold expansion of CD8 + T cells over a period of 5 days. This response eradicates the lymphoma and provides protection against tumor rechallenge without further antibody treatment. Thus, it seems that by treating mice with monoclonal antibody against CD40, we are immunizing against syngeneic tumors. The phenomenon proved reproducible with two antibodies against CD40 (3/23 and FGK-45) in three CD40+ lymphomas (A20, A31 and BCL1) and gave partial protection in one of two CD40? lymphomas (EL4 and Ten1). Although the nature of the target antigens on these lymphomas is unknown, CD8+ T cells recovered from responding mice showed powerful cytotoxic activity against the target B-cell lymphoma in vitro.
549-553
French, R.R.
a95ea7a1-7aeb-4c20-998e-fde663613fd1
Chan, H.T.C.
b109c93f-7e9a-44ee-ad12-da757b1b11fc
Tutt, A.L.
46ce577b-aea1-412d-84ea-fc4dab794469
Glennie, M.J.
9f6f0eff-4560-48c2-80cd-0ec116110ded
May 1999
French, R.R.
a95ea7a1-7aeb-4c20-998e-fde663613fd1
Chan, H.T.C.
b109c93f-7e9a-44ee-ad12-da757b1b11fc
Tutt, A.L.
46ce577b-aea1-412d-84ea-fc4dab794469
Glennie, M.J.
9f6f0eff-4560-48c2-80cd-0ec116110ded
French, R.R., Chan, H.T.C., Tutt, A.L. and Glennie, M.J.
(1999)
CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help.
Nature Medicine, 5 (5), .
(doi:10.1038/8426).
(PMID:10229232)
Abstract
CD40 is essential in enabling antigen-presenting cells to process and present antigen effectively to T cells. We demonstrate here that when antibody against CD40 is used to treat mice with syngeneic lymphoma, a rapid cytotoxic T-cell response independent of T-helper cells occurs, with tenfold expansion of CD8 + T cells over a period of 5 days. This response eradicates the lymphoma and provides protection against tumor rechallenge without further antibody treatment. Thus, it seems that by treating mice with monoclonal antibody against CD40, we are immunizing against syngeneic tumors. The phenomenon proved reproducible with two antibodies against CD40 (3/23 and FGK-45) in three CD40+ lymphomas (A20, A31 and BCL1) and gave partial protection in one of two CD40? lymphomas (EL4 and Ten1). Although the nature of the target antigens on these lymphomas is unknown, CD8+ T cells recovered from responding mice showed powerful cytotoxic activity against the target B-cell lymphoma in vitro.
This record has no associated files available for download.
More information
Published date: May 1999
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 362518
URI: http://eprints.soton.ac.uk/id/eprint/362518
ISSN: 1078-8956
PURE UUID: 0c0e7f24-db0a-4cf7-8a5f-fc643bd4178e
Catalogue record
Date deposited: 26 Feb 2014 12:44
Last modified: 15 Mar 2024 02:39
Export record
Altmetrics
Contributors
Author:
R.R. French
Author:
H.T.C. Chan
Author:
A.L. Tutt
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics